Michael Fürst


Michael Fürst has 20 years of experience in corporate responsibility, social business and innovation, and integrity and compliance management, in business and academia. He is currently having responsibilities for the implementation of the Novartis CR and access to medicines strategy, inclusive business model innovation, innovative finance, ESG investor relations, measurement and evaluation, materiality and stakeholder engagement.

Latest Articles

Opinion: The coming evaluation revolution in corporate responsibility
3 Oct 2018

Most companies want their corporate responsibility programs to work, but few develop the evidence base to understand whether they actually do. Experts weigh in on how to achieve social change at scale.